| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 5409 |
| 1 | METHOTREXATE SODIUM | 5381 |
| 2 | LEFLUNOMIDE | 5318 |
| 3 | DICLOFENAC SODIUM | 5311 |
| 4 | DICLOFENAC | 5220 |
| 5 | TOCILIZUMAB | 5213 |
| 6 | RITUXIMAB | 5186 |
| 7 | FOLIC ACID | 5134 |
| 8 | METHOTREXATE | 5134 |
| 9 | PREDNISONE | 5132 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLIMUMAB | 4685 | 0.3720 |
| 1 | CAFFEINE CITRATE | 854 | 0.3659 |
| 2 | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | 111 | 0.3616 |
| 3 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 197 | 0.2994 |
| 4 | CORTISONE ACETATE | 3537 | 0.2830 |
| 5 | PSEUDOEPHEDRINE HCL | 3050 | 0.2786 |
| 6 | DESOXIMETASONE | 4990 | 0.2589 |
| 7 | DICLOFENAC POTASSIUM TABLETS | 2149 | 0.2479 |
| 8 | TRICLOSAN | 143 | 0.2478 |
| 9 | HYDROCORTISONE BUTYRATE | 478 | 0.2419 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 6036 |
| 1 | Corticosteroid [EPC] | 5941 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 5829 |
| 3 | Vitamin C [EPC] | 5362 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 5346 |
| 5 | Antirheumatic Agent [EPC] | 5318 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 5260 |
| 7 | Vitamin B12 [EPC] | 5253 |
| 8 | Vitamin D [EPC] | 5159 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 5136 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 745 | 1.0828 |
| 1 | Endoglycosidase [EPC] | 268 | 0.1446 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 896 | 0.1027 |
| 3 | Interleukin-17A Antagonist [EPC] | 3186 | 0.0854 |
| 4 | Provitamin D2 Compound [EPC] | 2262 | 0.0760 |
| 5 | Antirheumatic Agent [EPC] | 5318 | 0.0503 |
| 6 | Aminosalicylate [EPC] | 4958 | 0.0492 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 5346 | 0.0386 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 2916 | 0.0346 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 4818 | 0.0344 |